This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Chong Kun Dang Pharmaceutical Corporation. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Jong Seo Choi: Innovator in Pharmaceutical Preparations
Introduction
Jong Seo Choi is a notable inventor based in Yongin-Si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 3 patents to his name, Choi's work focuses on enhancing the efficacy and stability of pharmaceutical compositions.
Latest Patents
Choi's latest patents include a pharmaceutical preparation that boasts excellent dissolution properties, containing esomeprazole and sodium bicarbonate. This invention relates to a method of preparing a pharmaceutical formulation where sodium bicarbonate is disintegrated to raise pH, allowing for improved dissolution and bioavailability of the active ingredient. Another significant patent is a stable pharmaceutical composition comprising esomeprazole and sodium bicarbonate, which offers improved stability and reduced side effects due to a lower dosage of sodium bicarbonate.
Career Highlights
Jong Seo Choi is currently associated with Chong Kun Dang Pharmaceutical Corporation, a leading company in the pharmaceutical industry. His work has been instrumental in advancing drug formulations that enhance patient outcomes.
Collaborations
Choi has collaborated with several talented individuals in his field, including Min Soo Kim and Shin Jung Park. These collaborations have contributed to the successful development of his innovative pharmaceutical preparations.
Conclusion
Jong Seo Choi's contributions to pharmaceutical innovations demonstrate his commitment to improving drug formulations. His patents reflect a deep understanding of pharmaceutical science and a dedication to enhancing patient care through effective medication.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile